News

Persist AI, a pioneer in AI-driven robotics for pharmaceutical formulation development and Chemistry, Manufacturing, and Controls (CMC), today announced the launch of its innovative Cloud Lab platform ...
Major pharmaceutical manufacturing company Eli Lilly is considering a $5.7 billion investment into a facility in Houston.
Global pharmaceutical giant Eli Lilly & Co. is considering a $5.9 billion plant in northeast Houston, a potential economic ...
With $27 billion earmarked to expand its U.S. production footprint starting this year, Eli Lilly is busy scouting out ...
Eli Lilly has proposed investing $5.9 billion to build a pharmaceutical facility in Houston's Generation Park.
The test can aid doctors in determining whether a patient's memory problems are due to Alzheimer's or a number of other ...